CA2628390A1

CA2628390A1 - Molecular profiling of cancer

Molecular profiling of cancer Download PDF

Info

Publication number: CA2628390A1
Authority: CA; Canada
Prior art keywords: cancer; expression; cancer marker; prostate; protein
Prior art date: 2005-11-02
Legal status : Abandoned

Application number

CA002628390A

Other languages

English (en)

French (fr)

Inventor

Arul Chinnaiyan

Sooryanarayana Lnu

Current Assignee

University of Michigan

Original Assignee

Individual

Priority date

2005-11-02

Filing date

2006-11-02

Publication date

2007-05-18

2006-11-02 Application filed by Individual filed Critical Individual

2007-05-18 Publication of CA2628390A1 publication Critical patent/CA2628390A1/en

Status Abandoned legal-status Critical Current

Links

206010028980 Neoplasm Diseases 0.000 title claims abstract description 197
201000011510 cancer Diseases 0.000 title claims abstract description 156
208000000236 Prostatic Neoplasms Diseases 0.000 claims abstract description 155
238000000034 method Methods 0.000 claims abstract description 120
210000002307 prostate Anatomy 0.000 claims abstract description 83
206010006187 Breast cancer Diseases 0.000 claims abstract description 19
208000026310 Breast neoplasm Diseases 0.000 claims abstract description 19
230000014509 gene expression Effects 0.000 claims description 166
206010060862 Prostate cancer Diseases 0.000 claims description 153
239000000439 tumor marker Substances 0.000 claims description 115
210000001519 tissue Anatomy 0.000 claims description 97
108020004999 messenger RNA Proteins 0.000 claims description 67
239000000523 sample Substances 0.000 claims description 65
230000027455 binding Effects 0.000 claims description 47
108090000765 processed proteins & peptides Proteins 0.000 claims description 45
102000004196 processed proteins & peptides Human genes 0.000 claims description 40
-1 PICIn Proteins 0.000 claims description 39
229920001184 polypeptide Polymers 0.000 claims description 38
208000010658 metastatic prostate carcinoma Diseases 0.000 claims description 31
239000003153 chemical reaction reagent Substances 0.000 claims description 30
238000001514 detection method Methods 0.000 claims description 29
230000000295 complement effect Effects 0.000 claims description 27
102100037024 E3 ubiquitin-protein ligase XIAP Human genes 0.000 claims description 21
102100026810 Cyclin-dependent kinase 7 Human genes 0.000 claims description 18
102100030960 DNA replication licensing factor MCM2 Human genes 0.000 claims description 18
101000911952 Homo sapiens Cyclin-dependent kinase 7 Proteins 0.000 claims description 18
101000583807 Homo sapiens DNA replication licensing factor MCM2 Proteins 0.000 claims description 18
102100031834 Unconventional myosin-VI Human genes 0.000 claims description 17
108010049787 myosin VI Proteins 0.000 claims description 17
102100024739 E3 ubiquitin-protein ligase UHRF1 Human genes 0.000 claims description 15
101000760417 Homo sapiens E3 ubiquitin-protein ligase UHRF1 Proteins 0.000 claims description 15
210000000481 breast Anatomy 0.000 claims description 15
230000001086 cytosolic effect Effects 0.000 claims description 15
108700031544 X-Linked Inhibitor of Apoptosis Proteins 0.000 claims description 13
238000004393 prognosis Methods 0.000 claims description 12
101100539164 Caenorhabditis elegans ubc-9 gene Proteins 0.000 claims description 11
102100022304 Junctional adhesion molecule A Human genes 0.000 claims description 11
102100023981 Lamina-associated polypeptide 2, isoform alpha Human genes 0.000 claims description 11
101100127339 Mus musculus Camkk1 gene Proteins 0.000 claims description 11
229940079593 drug Drugs 0.000 claims description 11
239000003814 drug Substances 0.000 claims description 11
102000043859 Dynamin Human genes 0.000 claims description 10
108700021058 Dynamin Proteins 0.000 claims description 10
101710097668 Leucine aminopeptidase 2 Proteins 0.000 claims description 10
YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 claims description 10
101710082686 probable leucine aminopeptidase 2 Proteins 0.000 claims description 10
102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 claims description 9
108010062228 Karyopherins Proteins 0.000 claims description 9
102000011781 Karyopherins Human genes 0.000 claims description 9
108020004711 Nucleic Acid Probes Proteins 0.000 claims description 9
102000005465 Stathmin Human genes 0.000 claims description 9
108050003387 Stathmin Proteins 0.000 claims description 9
238000000338 in vitro Methods 0.000 claims description 9
239000002853 nucleic acid probe Substances 0.000 claims description 9
102000004000 Aurora Kinase A Human genes 0.000 claims description 8
108090000461 Aurora Kinase A Proteins 0.000 claims description 8
101000804865 Homo sapiens E3 ubiquitin-protein ligase XIAP Proteins 0.000 claims description 8
101001046633 Homo sapiens Junctional adhesion molecule A Proteins 0.000 claims description 8
102100022893 Histone acetyltransferase KAT5 Human genes 0.000 claims description 6
101710116149 Histone acetyltransferase KAT5 Proteins 0.000 claims description 6
102000006275 Ubiquitin-Protein Ligases Human genes 0.000 claims description 6
108010083111 Ubiquitin-Protein Ligases Proteins 0.000 claims description 6
101000928788 Drosophila melanogaster Death-associated inhibitor of apoptosis 2 Proteins 0.000 claims description 5
101100481414 Mus musculus Trim28 gene Proteins 0.000 claims description 5
239000012502 diagnostic product Substances 0.000 claims description 4
201000001514 prostate carcinoma Diseases 0.000 claims description 2
239000000203 mixture Substances 0.000 abstract description 15
238000003745 diagnosis Methods 0.000 abstract description 13
238000012512 characterization method Methods 0.000 abstract description 6
108090000623 proteins and genes Proteins 0.000 description 395
102000004169 proteins and genes Human genes 0.000 description 231
210000004027 cell Anatomy 0.000 description 87
238000004458 analytical method Methods 0.000 description 65
150000001875 compounds Chemical class 0.000 description 65
150000007523 nucleic acids Chemical class 0.000 description 57
230000004075 alteration Effects 0.000 description 46
238000012360 testing method Methods 0.000 description 45
206010061289 metastatic neoplasm Diseases 0.000 description 41
102000039446 nucleic acids Human genes 0.000 description 41
108020004707 nucleic acids Proteins 0.000 description 41
108091032973 (ribonucleotides)n+m Proteins 0.000 description 39
108020004414 DNA Proteins 0.000 description 37
238000003556 assay Methods 0.000 description 34
241001465754 Metazoa Species 0.000 description 33
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 27
230000000694 effects Effects 0.000 description 25
102100038358 Prostate-specific antigen Human genes 0.000 description 24
201000010099 disease Diseases 0.000 description 23
238000009396 hybridization Methods 0.000 description 23
108010072866 Prostate-Specific Antigen Proteins 0.000 description 21
239000000047 product Substances 0.000 description 21
230000001105 regulatory effect Effects 0.000 description 21
108091034117 Oligonucleotide Proteins 0.000 description 20
238000002493 microarray Methods 0.000 description 20
108700019146 Transgenes Proteins 0.000 description 19
239000002773 nucleotide Substances 0.000 description 19
238000003119 immunoblot Methods 0.000 description 18
230000001965 increasing effect Effects 0.000 description 18
125000003729 nucleotide group Chemical group 0.000 description 18
238000006243 chemical reaction Methods 0.000 description 17
210000000981 epithelium Anatomy 0.000 description 17
239000000284 extract Substances 0.000 description 17
230000001394 metastastic effect Effects 0.000 description 17
238000012546 transfer Methods 0.000 description 17
101150043982 44 gene Proteins 0.000 description 16
108091028043 Nucleic acid sequence Proteins 0.000 description 16
238000013459 approach Methods 0.000 description 16
230000003993 interaction Effects 0.000 description 16
238000012216 screening Methods 0.000 description 16
238000010186 staining Methods 0.000 description 16
239000003098 androgen Substances 0.000 description 15
239000003795 chemical substances by application Substances 0.000 description 15
108091026890 Coding region Proteins 0.000 description 13
239000002299 complementary DNA Substances 0.000 description 13
230000006870 function Effects 0.000 description 13
239000000243 solution Substances 0.000 description 13
239000000758 substrate Substances 0.000 description 13
230000009261 transgenic effect Effects 0.000 description 13
108020004459 Small interfering RNA Proteins 0.000 description 12
238000002372 labelling Methods 0.000 description 12
102000040430 polynucleotide Human genes 0.000 description 12
108091033319 polynucleotide Proteins 0.000 description 12
239000002157 polynucleotide Substances 0.000 description 12
238000011282 treatment Methods 0.000 description 12
230000003247 decreasing effect Effects 0.000 description 11
230000002255 enzymatic effect Effects 0.000 description 11
239000003550 marker Substances 0.000 description 11
239000012528 membrane Substances 0.000 description 11
238000010200 validation analysis Methods 0.000 description 11
102000004190 Enzymes Human genes 0.000 description 10
108090000790 Enzymes Proteins 0.000 description 10
206010027476 Metastases Diseases 0.000 description 10
239000012634 fragment Substances 0.000 description 10
239000000499 gel Substances 0.000 description 10
239000013615 primer Substances 0.000 description 10
102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 description 9
102100038970 Histone-lysine N-methyltransferase EZH2 Human genes 0.000 description 9
101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 description 9
101000882127 Homo sapiens Histone-lysine N-methyltransferase EZH2 Proteins 0.000 description 9
238000000636 Northern blotting Methods 0.000 description 9
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
150000001413 amino acids Chemical class 0.000 description 9
239000000427 antigen Substances 0.000 description 9
102000036639 antigens Human genes 0.000 description 9
108091007433 antigens Proteins 0.000 description 9
230000000875 corresponding effect Effects 0.000 description 9
238000011503 in vivo imaging Methods 0.000 description 9
230000009401 metastasis Effects 0.000 description 9
239000013598 vector Substances 0.000 description 9
101150106774 9 gene Proteins 0.000 description 8
108091092195 Intron Proteins 0.000 description 8
102000018546 Paxillin Human genes 0.000 description 8
ACNHBCIZLNNLRS-UHFFFAOYSA-N Paxilline 1 Natural products N1C2=CC=CC=C2C2=C1C1(C)C3(C)CCC4OC(C(C)(O)C)C(=O)C=C4C3(O)CCC1C2 ACNHBCIZLNNLRS-UHFFFAOYSA-N 0.000 description 8
108091000080 Phosphotransferase Proteins 0.000 description 8
108700031954 Tgfb1i1/Leupaxin/TGFB1I1 Proteins 0.000 description 8
230000001419 dependent effect Effects 0.000 description 8
238000011161 development Methods 0.000 description 8
230000018109 developmental process Effects 0.000 description 8
210000004408 hybridoma Anatomy 0.000 description 8
231100000518 lethal Toxicity 0.000 description 8
230000001665 lethal effect Effects 0.000 description 8
102000020233 phosphotransferase Human genes 0.000 description 8
239000007787 solid Substances 0.000 description 8
239000007790 solid phase Substances 0.000 description 8
230000004083 survival effect Effects 0.000 description 8
238000001890 transfection Methods 0.000 description 8
238000005406 washing Methods 0.000 description 8
108060003951 Immunoglobulin Proteins 0.000 description 7
229910015837 MSH2 Inorganic materials 0.000 description 7
241000700605 Viruses Species 0.000 description 7
230000000692 anti-sense effect Effects 0.000 description 7
230000033228 biological regulation Effects 0.000 description 7
238000001574 biopsy Methods 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
102000018358 immunoglobulin Human genes 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
239000011159 matrix material Substances 0.000 description 7
230000001404 mediated effect Effects 0.000 description 7
ACNHBCIZLNNLRS-UBGQALKQSA-N paxilline Chemical compound N1C2=CC=CC=C2C2=C1[C@]1(C)[C@@]3(C)CC[C@@H]4O[C@H](C(C)(O)C)C(=O)C=C4[C@]3(O)CC[C@H]1C2 ACNHBCIZLNNLRS-UBGQALKQSA-N 0.000 description 7
230000008569 process Effects 0.000 description 7
238000012545 processing Methods 0.000 description 7
238000000926 separation method Methods 0.000 description 7
210000002966 serum Anatomy 0.000 description 7
241000894007 species Species 0.000 description 7
238000013518 transcription Methods 0.000 description 7
230000035897 transcription Effects 0.000 description 7
101000896484 Homo sapiens Mitotic checkpoint protein BUB3 Proteins 0.000 description 6
101000679903 Homo sapiens Tumor necrosis factor receptor superfamily member 25 Proteins 0.000 description 6
102100021718 Mitotic checkpoint protein BUB3 Human genes 0.000 description 6
102000048850 Neoplasm Genes Human genes 0.000 description 6
108700019961 Neoplasm Genes Proteins 0.000 description 6
239000002202 Polyethylene glycol Substances 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 6
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 6
210000000349 chromosome Anatomy 0.000 description 6
230000007423 decrease Effects 0.000 description 6
239000005556 hormone Substances 0.000 description 6
229940088597 hormone Drugs 0.000 description 6
230000002163 immunogen Effects 0.000 description 6
238000011065 in-situ storage Methods 0.000 description 6
239000002609 medium Substances 0.000 description 6
238000000520 microinjection Methods 0.000 description 6
230000037361 pathway Effects 0.000 description 6
230000026731 phosphorylation Effects 0.000 description 6
238000006366 phosphorylation reaction Methods 0.000 description 6
229920001223 polyethylene glycol Polymers 0.000 description 6
238000000746 purification Methods 0.000 description 6
230000001177 retroviral effect Effects 0.000 description 6
239000000126 substance Substances 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
102100039358 3-hydroxyacyl-CoA dehydrogenase type-2 Human genes 0.000 description 5
102000014914 Carrier Proteins Human genes 0.000 description 5
102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 description 5
108020004635 Complementary DNA Proteins 0.000 description 5
102100026561 Filamin-A Human genes 0.000 description 5
102100023324 Golgi SNAP receptor complex member 1 Human genes 0.000 description 5
102100031493 Growth arrest-specific protein 7 Human genes 0.000 description 5
101001035740 Homo sapiens 3-hydroxyacyl-CoA dehydrogenase type-2 Proteins 0.000 description 5
101000623903 Homo sapiens Cell surface glycoprotein MUC18 Proteins 0.000 description 5
101000829933 Homo sapiens Golgi SNAP receptor complex member 1 Proteins 0.000 description 5
101000923044 Homo sapiens Growth arrest-specific protein 7 Proteins 0.000 description 5
101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 description 5
102100039062 Interleukin enhancer-binding factor 3 Human genes 0.000 description 5
102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 description 5
102100039767 Ras-related protein Rab-27A Human genes 0.000 description 5
102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 5
230000001580 bacterial effect Effects 0.000 description 5
239000011324 bead Substances 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
239000000872 buffer Substances 0.000 description 5
239000000975 dye Substances 0.000 description 5
238000001962 electrophoresis Methods 0.000 description 5
238000010195 expression analysis Methods 0.000 description 5
238000003384 imaging method Methods 0.000 description 5
238000001727 in vivo Methods 0.000 description 5
230000001939 inductive effect Effects 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
210000004940 nucleus Anatomy 0.000 description 5
238000000575 proteomic method Methods 0.000 description 5
108010033990 rab27 GTP-Binding Proteins Proteins 0.000 description 5
230000001225 therapeutic effect Effects 0.000 description 5
238000002560 therapeutic procedure Methods 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
102100032187 Androgen receptor Human genes 0.000 description 4
108091007065 BIRCs Proteins 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
206010018338 Glioma Diseases 0.000 description 4
108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 description 4
102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 description 4
101150073847 Mmp23 gene Proteins 0.000 description 4
QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 4
239000000020 Nitrocellulose Substances 0.000 description 4
102100035703 Prostatic acid phosphatase Human genes 0.000 description 4
206010038997 Retroviral infections Diseases 0.000 description 4
102100024790 SWI/SNF complex subunit SMARCC2 Human genes 0.000 description 4
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
230000003321 amplification Effects 0.000 description 4
108010080146 androgen receptors Proteins 0.000 description 4
230000006907 apoptotic process Effects 0.000 description 4
230000015556 catabolic process Effects 0.000 description 4
230000021615 conjugation Effects 0.000 description 4
238000006731 degradation reaction Methods 0.000 description 4
239000003623 enhancer Substances 0.000 description 4
210000002919 epithelial cell Anatomy 0.000 description 4
230000004927 fusion Effects 0.000 description 4
108020001507 fusion proteins Proteins 0.000 description 4
102000037865 fusion proteins Human genes 0.000 description 4
239000007789 gas Substances 0.000 description 4
230000009368 gene silencing by RNA Effects 0.000 description 4
210000004602 germ cell Anatomy 0.000 description 4
238000003018 immunoassay Methods 0.000 description 4
229940055742 indium-111 Drugs 0.000 description 4
APFVFJFRJDLVQX-AHCXROLUSA-N indium-111 Chemical compound [111In] APFVFJFRJDLVQX-AHCXROLUSA-N 0.000 description 4
239000003112 inhibitor Substances 0.000 description 4
230000000977 initiatory effect Effects 0.000 description 4
102000006495 integrins Human genes 0.000 description 4
108010044426 integrins Proteins 0.000 description 4
230000000670 limiting effect Effects 0.000 description 4
210000001161 mammalian embryo Anatomy 0.000 description 4
229920001220 nitrocellulos Polymers 0.000 description 4
230000009871 nonspecific binding Effects 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
238000007899 nucleic acid hybridization Methods 0.000 description 4
230000036961 partial effect Effects 0.000 description 4
229960003330 pentetic acid Drugs 0.000 description 4
230000008488 polyadenylation Effects 0.000 description 4
238000001556 precipitation Methods 0.000 description 4
238000011472 radical prostatectomy Methods 0.000 description 4
230000002285 radioactive effect Effects 0.000 description 4
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
230000007704 transition Effects 0.000 description 4
241001430294 unidentified retrovirus Species 0.000 description 4
QAPSNMNOIOSXSQ-YNEHKIRRSA-N 1-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)C1 QAPSNMNOIOSXSQ-YNEHKIRRSA-N 0.000 description 3
102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 description 3
241000972773 Aulopiformes Species 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
241000283707 Capra Species 0.000 description 3
108010078791 Carrier Proteins Proteins 0.000 description 3
108090000397 Caspase 3 Proteins 0.000 description 3
102100029855 Caspase-3 Human genes 0.000 description 3
102100038902 Caspase-7 Human genes 0.000 description 3
102000005600 Cathepsins Human genes 0.000 description 3
108010084457 Cathepsins Proteins 0.000 description 3
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 3
102100032918 Chromobox protein homolog 5 Human genes 0.000 description 3
108050006400 Cyclin Proteins 0.000 description 3
108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 3
102100031051 Cysteine and glycine-rich protein 1 Human genes 0.000 description 3
102000053602 DNA Human genes 0.000 description 3
230000004543 DNA replication Effects 0.000 description 3
102100033720 DNA replication licensing factor MCM6 Human genes 0.000 description 3
102100036337 Dematin Human genes 0.000 description 3
102100031250 Disks large-associated protein 1 Human genes 0.000 description 3
102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 description 3
102100026620 E3 ubiquitin ligase TRAF3IP2 Human genes 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
102000001267 GSK3 Human genes 0.000 description 3
108060006662 GSK3 Proteins 0.000 description 3
208000032612 Glial tumor Diseases 0.000 description 3
102100038104 Glycogen synthase kinase-3 beta Human genes 0.000 description 3
241000282412 Homo Species 0.000 description 3
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 3
101001018484 Homo sapiens DNA replication licensing factor MCM6 Proteins 0.000 description 3
101000844784 Homo sapiens Disks large-associated protein 1 Proteins 0.000 description 3
101001115395 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 4 Proteins 0.000 description 3
101000913549 Homo sapiens Filamin-A Proteins 0.000 description 3
101000994369 Homo sapiens Integrin alpha-5 Proteins 0.000 description 3
101001011896 Homo sapiens Matrix metalloproteinase-19 Proteins 0.000 description 3
101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 description 3
101000927796 Homo sapiens Rho guanine nucleotide exchange factor 7 Proteins 0.000 description 3
101000687720 Homo sapiens SWI/SNF complex subunit SMARCC2 Proteins 0.000 description 3
101000987315 Homo sapiens Serine/threonine-protein kinase PAK 3 Proteins 0.000 description 3
101000702545 Homo sapiens Transcription activator BRG1 Proteins 0.000 description 3
101000904150 Homo sapiens Transcription factor E2F3 Proteins 0.000 description 3
101000801227 Homo sapiens Tumor necrosis factor receptor superfamily member 19 Proteins 0.000 description 3
101000610980 Homo sapiens Tumor protein D52 Proteins 0.000 description 3
102100032817 Integrin alpha-5 Human genes 0.000 description 3
108010040082 Junctional Adhesion Molecule A Proteins 0.000 description 3
102100026797 Kanadaptin Human genes 0.000 description 3
101710155163 Kanadaptin Proteins 0.000 description 3
108060001084 Luciferase Proteins 0.000 description 3
102100028397 MAP kinase-activated protein kinase 3 Human genes 0.000 description 3
208000035346 Margins of Excision Diseases 0.000 description 3
108090000587 Matrix metalloproteinase-19 Proteins 0.000 description 3
102000004055 Matrix metalloproteinase-19 Human genes 0.000 description 3
102100030218 Matrix metalloproteinase-19 Human genes 0.000 description 3
102100024130 Matrix metalloproteinase-23 Human genes 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 3
206010061309 Neoplasm progression Diseases 0.000 description 3
239000004677 Nylon Substances 0.000 description 3
108700020796 Oncogene Proteins 0.000 description 3
239000002033 PVDF binder Substances 0.000 description 3
102000035195 Peptidases Human genes 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
108010043958 Peptoids Proteins 0.000 description 3
102100036691 Proliferating cell nuclear antigen Human genes 0.000 description 3
239000004365 Protease Substances 0.000 description 3
102100022340 SHC-transforming protein 1 Human genes 0.000 description 3
108091081021 Sense strand Proteins 0.000 description 3
102100027911 Serine/threonine-protein kinase PAK 3 Human genes 0.000 description 3
238000002105 Southern blotting Methods 0.000 description 3
108010090804 Streptavidin Proteins 0.000 description 3
102100031027 Transcription activator BRG1 Human genes 0.000 description 3
102100024027 Transcription factor E2F3 Human genes 0.000 description 3
101710177718 Transcription intermediary factor 1-beta Proteins 0.000 description 3
102100022012 Transcription intermediary factor 1-beta Human genes 0.000 description 3
101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 description 3
102100033760 Tumor necrosis factor receptor superfamily member 19 Human genes 0.000 description 3
102100040418 Tumor protein D52 Human genes 0.000 description 3
125000000539 amino acid group Chemical group 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
239000000090 biomarker Substances 0.000 description 3
210000004952 blastocoel Anatomy 0.000 description 3
210000001109 blastomere Anatomy 0.000 description 3
231100000504 carcinogenesis Toxicity 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
230000007910 cell fusion Effects 0.000 description 3
230000010261 cell growth Effects 0.000 description 3
239000002738 chelating agent Substances 0.000 description 3
230000008878 coupling Effects 0.000 description 3
238000010168 coupling process Methods 0.000 description 3
238000005859 coupling reaction Methods 0.000 description 3
210000000172 cytosol Anatomy 0.000 description 3
239000005547 deoxyribonucleotide Substances 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
239000007850 fluorescent dye Substances 0.000 description 3
238000011331 genomic analysis Methods 0.000 description 3
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
238000001794 hormone therapy Methods 0.000 description 3
230000016784 immunoglobulin production Effects 0.000 description 3
229940072221 immunoglobulins Drugs 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
150000002500 ions Chemical class 0.000 description 3
210000001165 lymph node Anatomy 0.000 description 3
230000005291 magnetic effect Effects 0.000 description 3
238000002595 magnetic resonance imaging Methods 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
210000003632 microfilament Anatomy 0.000 description 3
235000019799 monosodium phosphate Nutrition 0.000 description 3
NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 description 3
230000001613 neoplastic effect Effects 0.000 description 3
229920001778 nylon Polymers 0.000 description 3
229920002981 polyvinylidene fluoride Polymers 0.000 description 3
238000002600 positron emission tomography Methods 0.000 description 3
230000004481 post-translational protein modification Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000006798 recombination Effects 0.000 description 3
238000005215 recombination Methods 0.000 description 3
238000011160 research Methods 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
238000012340 reverse transcriptase PCR Methods 0.000 description 3
238000012552 review Methods 0.000 description 3
235000019515 salmon Nutrition 0.000 description 3
230000019491 signal transduction Effects 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 3
229910000162 sodium phosphate Inorganic materials 0.000 description 3
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 3
210000001578 tight junction Anatomy 0.000 description 3
238000012549 training Methods 0.000 description 3
210000004881 tumor cell Anatomy 0.000 description 3
230000005751 tumor progression Effects 0.000 description 3
210000002700 urine Anatomy 0.000 description 3
238000001262 western blot Methods 0.000 description 3
HPZMWTNATZPBIH-UHFFFAOYSA-N 1-methyladenine Chemical compound CN1C=NC2=NC=NC2=C1N HPZMWTNATZPBIH-UHFFFAOYSA-N 0.000 description 2
RFLVMTUMFYRZCB-UHFFFAOYSA-N 1-methylguanine Chemical compound O=C1N(C)C(N)=NC2=C1N=CN2 RFLVMTUMFYRZCB-UHFFFAOYSA-N 0.000 description 2
YSAJFXWTVFGPAX-UHFFFAOYSA-N 2-[(2,4-dioxo-1h-pyrimidin-5-yl)oxy]acetic acid Chemical compound OC(=O)COC1=CNC(=O)NC1=O YSAJFXWTVFGPAX-UHFFFAOYSA-N 0.000 description 2
WYMDDFRYORANCC-UHFFFAOYSA-N 2-[[3-[bis(carboxymethyl)amino]-2-hydroxypropyl]-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)CN(CC(O)=O)CC(O)=O WYMDDFRYORANCC-UHFFFAOYSA-N 0.000 description 2
FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
102100037263 3-phosphoinositide-dependent protein kinase 1 Human genes 0.000 description 2
OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1h-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 2
102100033400 4F2 cell-surface antigen heavy chain Human genes 0.000 description 2
OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 description 2
DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1h-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 2
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
102100034613 Annexin A2 Human genes 0.000 description 2
101100385562 Arabidopsis thaliana CSTF50 gene Proteins 0.000 description 2
102100032311 Aurora kinase A Human genes 0.000 description 2
102000017915 BDKRB2 Human genes 0.000 description 2
102100026596 Bcl-2-like protein 1 Human genes 0.000 description 2
101150008012 Bcl2l1 gene Proteins 0.000 description 2
206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
102000015735 Beta-catenin Human genes 0.000 description 2
108060000903 Beta-catenin Proteins 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
102100026437 Branched-chain-amino-acid aminotransferase, cytosolic Human genes 0.000 description 2
102100025752 CASP8 and FADD-like apoptosis regulator Human genes 0.000 description 2
101100256089 Caenorhabditis elegans uba-2 gene Proteins 0.000 description 2
102100021534 Calcium/calmodulin-dependent protein kinase kinase 2 Human genes 0.000 description 2
102100032378 Carboxypeptidase E Human genes 0.000 description 2
108010058255 Carboxypeptidase H Proteins 0.000 description 2
208000005623 Carcinogenesis Diseases 0.000 description 2
108090000567 Caspase 7 Proteins 0.000 description 2
102000003908 Cathepsin D Human genes 0.000 description 2
102100032219 Cathepsin D Human genes 0.000 description 2
108090000258 Cathepsin D Proteins 0.000 description 2
102100032230 Caveolae-associated protein 1 Human genes 0.000 description 2
102000009193 Caveolin Human genes 0.000 description 2
108050000084 Caveolin Proteins 0.000 description 2
108010058432 Chaperonin 60 Proteins 0.000 description 2
108010077544 Chromatin Proteins 0.000 description 2
108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 2
101710185487 Cysteine and glycine-rich protein 1 Proteins 0.000 description 2
101710088199 Dematin Proteins 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
101150039033 Eci2 gene Proteins 0.000 description 2
102100021823 Enoyl-CoA delta isomerase 2 Human genes 0.000 description 2
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
101100058548 Felis catus BMI1 gene Proteins 0.000 description 2
101710091743 Filamin-A Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
GYHNNYVSQQEPJS-OIOBTWANSA-N Gallium-67 Chemical compound [67Ga] GYHNNYVSQQEPJS-OIOBTWANSA-N 0.000 description 2
GYHNNYVSQQEPJS-YPZZEJLDSA-N Gallium-68 Chemical compound [68Ga] GYHNNYVSQQEPJS-YPZZEJLDSA-N 0.000 description 2
229920002527 Glycogen Polymers 0.000 description 2
101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 2
101000800023 Homo sapiens 4F2 cell-surface antigen heavy chain Proteins 0.000 description 2
101000798300 Homo sapiens Aurora kinase A Proteins 0.000 description 2
101000695703 Homo sapiens B2 bradykinin receptor Proteins 0.000 description 2
101000741014 Homo sapiens Caspase-7 Proteins 0.000 description 2
101000869010 Homo sapiens Cathepsin D Proteins 0.000 description 2
101000869049 Homo sapiens Caveolae-associated protein 1 Proteins 0.000 description 2
101000913784 Homo sapiens E3 ubiquitin ligase TRAF3IP2 Proteins 0.000 description 2
101001044940 Homo sapiens Insulin-like growth factor-binding protein 2 Proteins 0.000 description 2
101001033293 Homo sapiens Interleukin enhancer-binding factor 3 Proteins 0.000 description 2
101000627851 Homo sapiens Matrix metalloproteinase-23 Proteins 0.000 description 2
101000969087 Homo sapiens Microtubule-associated protein 2 Proteins 0.000 description 2
101000962664 Homo sapiens Microtubule-associated protein RP/EB family member 1 Proteins 0.000 description 2
101001124017 Homo sapiens Nuclear transport factor 2 Proteins 0.000 description 2
101001086785 Homo sapiens Occludin Proteins 0.000 description 2
101000878253 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 description 2
101000872170 Homo sapiens Polycomb complex protein BMI-1 Proteins 0.000 description 2
101001051777 Homo sapiens Protein kinase C alpha type Proteins 0.000 description 2
101000610602 Homo sapiens Tumor necrosis factor receptor superfamily member 10C Proteins 0.000 description 2
101001087394 Homo sapiens Tyrosine-protein phosphatase non-receptor type 1 Proteins 0.000 description 2
101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 description 2
206010062904 Hormone-refractory prostate cancer Diseases 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
101150003028 Hprt1 gene Proteins 0.000 description 2
238000009015 Human TaqMan MicroRNA Assay kit Methods 0.000 description 2
102100022710 Insulin-like growth factor-binding protein 2 Human genes 0.000 description 2
102100036342 Interleukin-1 receptor-associated kinase 1 Human genes 0.000 description 2
238000010824 Kaplan-Meier survival analysis Methods 0.000 description 2
238000001295 Levene's test Methods 0.000 description 2
239000005089 Luciferase Substances 0.000 description 2
206010058467 Lung neoplasm malignant Diseases 0.000 description 2
101150053046 MYD88 gene Proteins 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
108060004795 Methyltransferase Proteins 0.000 description 2
102000016397 Methyltransferase Human genes 0.000 description 2
102100021118 Microtubule-associated protein 2 Human genes 0.000 description 2
102100039560 Microtubule-associated protein RP/EB family member 1 Human genes 0.000 description 2
101100065487 Mus musculus Epha4 gene Proteins 0.000 description 2
101100180382 Mus musculus Jaml gene Proteins 0.000 description 2
101100208721 Mus musculus Usp5 gene Proteins 0.000 description 2
102100024134 Myeloid differentiation primary response protein MyD88 Human genes 0.000 description 2
101710198035 Myosin light chain kinase, smooth muscle Proteins 0.000 description 2
108010074596 Myosin-Light-Chain Kinase Proteins 0.000 description 2
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
HYVABZIGRDEKCD-UHFFFAOYSA-N N(6)-dimethylallyladenine Chemical compound CC(C)=CCNC1=NC=NC2=C1N=CN2 HYVABZIGRDEKCD-UHFFFAOYSA-N 0.000 description 2
102100031801 Nexilin Human genes 0.000 description 2
102100028418 Nuclear transport factor 2 Human genes 0.000 description 2
102100032604 Occludin Human genes 0.000 description 2
108020005187 Oligonucleotide Probes Proteins 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
102100033566 Polycomb complex protein BMI-1 Human genes 0.000 description 2
108010022429 Polycomb-Group Proteins Proteins 0.000 description 2
102000012425 Polycomb-Group Proteins Human genes 0.000 description 2
102100029500 Prostasin Human genes 0.000 description 2
208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
102100024924 Protein kinase C alpha type Human genes 0.000 description 2
101800004062 Protein p23 Proteins 0.000 description 2
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 2
108091030071 RNAI Proteins 0.000 description 2
102100031424 Ras-related protein Ral-A Human genes 0.000 description 2
101000881112 Rattus norvegicus Dual specificity protein phosphatase 12 Proteins 0.000 description 2
102000007508 Retinoblastoma-Binding Protein 4 Human genes 0.000 description 2
108010071034 Retinoblastoma-Binding Protein 4 Proteins 0.000 description 2
102100024908 Ribosomal protein S6 kinase beta-1 Human genes 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
102000002669 Small Ubiquitin-Related Modifier Proteins Human genes 0.000 description 2
108010043401 Small Ubiquitin-Related Modifier Proteins Proteins 0.000 description 2
102100024237 Stathmin Human genes 0.000 description 2
238000000692 Student's t-test Methods 0.000 description 2
102100028644 Tenascin-R Human genes 0.000 description 2
MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102100033459 Transforming growth factor beta-1-induced transcript 1 protein Human genes 0.000 description 2
101710188061 Transforming growth factor beta-1-induced transcript 1 protein Proteins 0.000 description 2
102100040115 Tumor necrosis factor receptor superfamily member 10C Human genes 0.000 description 2
102100022203 Tumor necrosis factor receptor superfamily member 25 Human genes 0.000 description 2
102000007537 Type II DNA Topoisomerases Human genes 0.000 description 2
108010046308 Type II DNA Topoisomerases Proteins 0.000 description 2
102100033001 Tyrosine-protein phosphatase non-receptor type 1 Human genes 0.000 description 2
241000251539 Vertebrata <Metazoa> Species 0.000 description 2
102000002258 X-ray Repair Cross Complementing Protein 1 Human genes 0.000 description 2
108010000443 X-ray Repair Cross Complementing Protein 1 Proteins 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000012190 activator Substances 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
238000007818 agglutination assay Methods 0.000 description 2
238000010171 animal model Methods 0.000 description 2
210000000628 antibody-producing cell Anatomy 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
229940041181 antineoplastic drug Drugs 0.000 description 2
229910052785 arsenic Inorganic materials 0.000 description 2
210000000270 basal cell Anatomy 0.000 description 2
108700000711 bcl-X Proteins 0.000 description 2
108091008324 binding proteins Proteins 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
230000008236 biological pathway Effects 0.000 description 2
239000012472 biological sample Substances 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
210000002459 blastocyst Anatomy 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
230000036952 cancer formation Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
210000003483 chromatin Anatomy 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
238000007621 cluster analysis Methods 0.000 description 2
238000000975 co-precipitation Methods 0.000 description 2
230000003081 coactivator Effects 0.000 description 2
238000004891 communication Methods 0.000 description 2
230000009918 complex formation Effects 0.000 description 2
239000000356 contaminant Substances 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
238000012258 culturing Methods 0.000 description 2
238000007405 data analysis Methods 0.000 description 2
125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
229960002086 dextran Drugs 0.000 description 2
238000002405 diagnostic procedure Methods 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
230000003828 downregulation Effects 0.000 description 2
238000007877 drug screening Methods 0.000 description 2
239000012636 effector Substances 0.000 description 2
235000013601 eggs Nutrition 0.000 description 2
210000002257 embryonic structure Anatomy 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
229940006110 gallium-67 Drugs 0.000 description 2
238000002523 gelfiltration Methods 0.000 description 2
230000037442 genomic alteration Effects 0.000 description 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
229940096919 glycogen Drugs 0.000 description 2
239000010931 gold Substances 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
230000036541 health Effects 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
230000003054 hormonal effect Effects 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
230000003053 immunization Effects 0.000 description 2
238000002649 immunization Methods 0.000 description 2
238000002991 immunohistochemical analysis Methods 0.000 description 2
238000003364 immunohistochemistry Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
239000003446 ligand Substances 0.000 description 2
238000001638 lipofection Methods 0.000 description 2
239000002502 liposome Substances 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
201000005202 lung cancer Diseases 0.000 description 2
208000020816 lung neoplasm Diseases 0.000 description 2
239000006166 lysate Substances 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
238000005259 measurement Methods 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
238000010208 microarray analysis Methods 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
230000033607 mismatch repair Effects 0.000 description 2
210000001700 mitochondrial membrane Anatomy 0.000 description 2
238000007479 molecular analysis Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
230000035772 mutation Effects 0.000 description 2
238000013188 needle biopsy Methods 0.000 description 2
230000009826 neoplastic cell growth Effects 0.000 description 2
108010054109 nuclear pore protein p62 Proteins 0.000 description 2
239000002751 oligonucleotide probe Substances 0.000 description 2
238000011275 oncology therapy Methods 0.000 description 2
238000001543 one-way ANOVA Methods 0.000 description 2
210000000287 oocyte Anatomy 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
230000002018 overexpression Effects 0.000 description 2
238000003068 pathway analysis Methods 0.000 description 2
239000013610 patient sample Substances 0.000 description 2
239000013612 plasmid Substances 0.000 description 2
238000010149 post-hoc-test Methods 0.000 description 2
230000032361 posttranscriptional gene silencing Effects 0.000 description 2
239000002243 precursor Substances 0.000 description 2
238000002203 pretreatment Methods 0.000 description 2
210000005267 prostate cell Anatomy 0.000 description 2
208000023958 prostate neoplasm Diseases 0.000 description 2
210000001938 protoplast Anatomy 0.000 description 2
230000005855 radiation Effects 0.000 description 2
239000000941 radioactive substance Substances 0.000 description 2
230000000306 recurrent effect Effects 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000007423 screening assay Methods 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
239000013589 supplement Substances 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
238000012353 t test Methods 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
238000013519 translation Methods 0.000 description 2
230000003827 upregulation Effects 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
YMXHPSHLTSZXKH-RVBZMBCESA-N (2,5-dioxopyrrolidin-1-yl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)ON1C(=O)CCC1=O YMXHPSHLTSZXKH-RVBZMBCESA-N 0.000 description 1
PJOHVEQSYPOERL-SHEAVXILSA-N (e)-n-[(4r,4as,7ar,12br)-3-(cyclopropylmethyl)-9-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-4a-yl]-3-(4-methylphenyl)prop-2-enamide Chemical compound C1=CC(C)=CC=C1\C=C\C(=O)N[C@]1(CCC(=O)[C@@H]2O3)[C@H]4CC5=CC=C(O)C3=C5[C@]12CCN4CC1CC1 PJOHVEQSYPOERL-SHEAVXILSA-N 0.000 description 1
SATCOUWSAZBIJO-UHFFFAOYSA-N 1-methyladenine Natural products N=C1N(C)C=NC2=C1NC=N2 SATCOUWSAZBIJO-UHFFFAOYSA-N 0.000 description 1
WJNGQIYEQLPJMN-IOSLPCCCSA-N 1-methylinosine Chemical compound C1=NC=2C(=O)N(C)C=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WJNGQIYEQLPJMN-IOSLPCCCSA-N 0.000 description 1
PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 1
HLYBTPMYFWWNJN-UHFFFAOYSA-N 2-(2,4-dioxo-1h-pyrimidin-5-yl)-2-hydroxyacetic acid Chemical compound OC(=O)C(O)C1=CNC(=O)NC1=O HLYBTPMYFWWNJN-UHFFFAOYSA-N 0.000 description 1
MFSSHRCJKRDIOL-UHFFFAOYSA-N 2-(2-fluorophenoxy)-4-(2-methylpyrazol-3-yl)benzamide Chemical compound CN1C(=CC=N1)C2=CC(=C(C=C2)C(=O)N)OC3=CC=CC=C3F MFSSHRCJKRDIOL-UHFFFAOYSA-N 0.000 description 1
SVBOROZXXYRWJL-UHFFFAOYSA-N 2-[(4-oxo-2-sulfanylidene-1h-pyrimidin-5-yl)methylamino]acetic acid Chemical compound OC(=O)CNCC1=CNC(=S)NC1=O SVBOROZXXYRWJL-UHFFFAOYSA-N 0.000 description 1
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
XMSMHKMPBNTBOD-UHFFFAOYSA-N 2-dimethylamino-6-hydroxypurine Chemical compound N1C(N(C)C)=NC(=O)C2=C1N=CN2 XMSMHKMPBNTBOD-UHFFFAOYSA-N 0.000 description 1
SMADWRYCYBUIKH-UHFFFAOYSA-N 2-methyl-7h-purin-6-amine Chemical compound CC1=NC(N)=C2NC=NC2=N1 SMADWRYCYBUIKH-UHFFFAOYSA-N 0.000 description 1
108020005065 3' Flanking Region Proteins 0.000 description 1
KOLPWZCZXAMXKS-UHFFFAOYSA-N 3-methylcytosine Chemical compound CN1C(N)=CC=NC1=O KOLPWZCZXAMXKS-UHFFFAOYSA-N 0.000 description 1
101150033839 4 gene Proteins 0.000 description 1
GJAKJCICANKRFD-UHFFFAOYSA-N 4-acetyl-4-amino-1,3-dihydropyrimidin-2-one Chemical compound CC(=O)C1(N)NC(=O)NC=C1 GJAKJCICANKRFD-UHFFFAOYSA-N 0.000 description 1
TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
102100022530 45 kDa calcium-binding protein Human genes 0.000 description 1
101710168918 45 kDa calcium-binding protein Proteins 0.000 description 1
108020005029 5' Flanking Region Proteins 0.000 description 1
MQJSSLBGAQJNER-UHFFFAOYSA-N 5-(methylaminomethyl)-1h-pyrimidine-2,4-dione Chemical compound CNCC1=CNC(=O)NC1=O MQJSSLBGAQJNER-UHFFFAOYSA-N 0.000 description 1
WPYRHVXCOQLYLY-UHFFFAOYSA-N 5-[(methoxyamino)methyl]-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CONCC1=CNC(=S)NC1=O WPYRHVXCOQLYLY-UHFFFAOYSA-N 0.000 description 1
KELXHQACBIUYSE-UHFFFAOYSA-N 5-methoxy-1h-pyrimidine-2,4-dione Chemical compound COC1=CNC(=O)NC1=O KELXHQACBIUYSE-UHFFFAOYSA-N 0.000 description 1
ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
101150052384 50 gene Proteins 0.000 description 1
HSPHKCOAUOJLIO-UHFFFAOYSA-N 6-(aziridin-1-ylamino)-1h-pyrimidin-2-one Chemical compound N1C(=O)N=CC=C1NN1CC1 HSPHKCOAUOJLIO-UHFFFAOYSA-N 0.000 description 1
CKOMXBHMKXXTNW-UHFFFAOYSA-N 6-methyladenine Chemical compound CNC1=NC=NC2=C1N=CN2 CKOMXBHMKXXTNW-UHFFFAOYSA-N 0.000 description 1
MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
102100026656 Actin, alpha skeletal muscle Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
241000701242 Adenoviridae Species 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
102100027211 Albumin Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
102100040121 Allograft inflammatory factor 1 Human genes 0.000 description 1
102000003730 Alpha-catenin Human genes 0.000 description 1
108090000020 Alpha-catenin Proteins 0.000 description 1
102100040743 Alpha-crystallin B chain Human genes 0.000 description 1
102100026882 Alpha-synuclein Human genes 0.000 description 1
101710154825 Aminoglycoside 3'-phosphotransferase Proteins 0.000 description 1
102000000412 Annexin Human genes 0.000 description 1
108050008874 Annexin Proteins 0.000 description 1
108090000668 Annexin A2 Proteins 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 1
108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
241000271566 Aves Species 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
108010028006 B-Cell Activating Factor Proteins 0.000 description 1
101150059057 BET1 gene Proteins 0.000 description 1
102100028168 BET1 homolog Human genes 0.000 description 1
102000051485 Bcl-2 family Human genes 0.000 description 1
108700038897 Bcl-2 family Proteins 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
101150019620 CAD gene Proteins 0.000 description 1
101710100501 CASP8 and FADD-like apoptosis regulator Proteins 0.000 description 1
108091007381 CBL proteins Proteins 0.000 description 1
102000000905 Cadherin Human genes 0.000 description 1
108050007957 Cadherin Proteins 0.000 description 1
101100264195 Caenorhabditis elegans app-1 gene Proteins 0.000 description 1
101100179415 Caenorhabditis elegans eif-6 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102100021868 Calnexin Human genes 0.000 description 1
241000282465 Canis Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
102100034357 Casein kinase I isoform alpha Human genes 0.000 description 1
102000004041 Caspase 7 Human genes 0.000 description 1
102100026548 Caspase-8 Human genes 0.000 description 1
102100028906 Catenin delta-1 Human genes 0.000 description 1
102100038909 Caveolin-2 Human genes 0.000 description 1
241000700198 Cavia Species 0.000 description 1
208000031404 Chromosome Aberrations Diseases 0.000 description 1
102100040268 Cleavage stimulation factor subunit 1 Human genes 0.000 description 1
108091033380 Coding strand Proteins 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
102000000989 Complement System Proteins Human genes 0.000 description 1
108010069112 Complement System Proteins Proteins 0.000 description 1
102100038607 Cullin-associated NEDD8-dissociated protein 1 Human genes 0.000 description 1
102000003910 Cyclin D Human genes 0.000 description 1
108090000259 Cyclin D Proteins 0.000 description 1
102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 description 1
102100038026 DNA fragmentation factor subunit alpha Human genes 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
102100037373 DNA-(apurinic or apyrimidinic site) endonuclease Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
101000876610 Dictyostelium discoideum Extracellular signal-regulated kinase 2 Proteins 0.000 description 1
102100034581 Dihydroorotase Human genes 0.000 description 1
241001269524 Dura Species 0.000 description 1
102100021236 Dynamin-1 Human genes 0.000 description 1
102100021238 Dynamin-2 Human genes 0.000 description 1
102100025682 Dystroglycan 1 Human genes 0.000 description 1
108010071885 Dystroglycans Proteins 0.000 description 1
101710140859 E3 ubiquitin ligase TRAF3IP2 Proteins 0.000 description 1
102100035275 E3 ubiquitin-protein ligase CBL-C Human genes 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
102100040002 Eukaryotic translation initiation factor 6 Human genes 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
102100025637 FACT complex subunit SPT16 Human genes 0.000 description 1
241000282324 Felis Species 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
102000013366 Filamin Human genes 0.000 description 1
108060002900 Filamin Proteins 0.000 description 1
238000000729 Fisher's exact test Methods 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
241000233866 Fungi Species 0.000 description 1
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
102100033425 GDNF family receptor alpha-2 Human genes 0.000 description 1
102000038624 GSKs Human genes 0.000 description 1
108091007911 GSKs Proteins 0.000 description 1
102100038073 General transcription factor II-I Human genes 0.000 description 1
208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
208000031448 Genomic Instability Diseases 0.000 description 1
102100021223 Glucosidase 2 subunit beta Human genes 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
102000005720 Glutathione transferase Human genes 0.000 description 1
108010070675 Glutathione transferase Proteins 0.000 description 1
102000019058 Glycogen Synthase Kinase 3 beta Human genes 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102100025296 Guanine nucleotide-binding protein G(o) subunit alpha Human genes 0.000 description 1
241001326189 Gyrodactylus prostae Species 0.000 description 1
101150009006 HIS3 gene Proteins 0.000 description 1
229920000209 Hexadimethrine bromide Polymers 0.000 description 1
108010033040 Histones Proteins 0.000 description 1
102000006947 Histones Human genes 0.000 description 1
101000691599 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 Proteins 0.000 description 1
101000883686 Homo sapiens 60 kDa heat shock protein, mitochondrial Proteins 0.000 description 1
101000834207 Homo sapiens Actin, alpha skeletal muscle Proteins 0.000 description 1
101000890626 Homo sapiens Allograft inflammatory factor 1 Proteins 0.000 description 1
101000891982 Homo sapiens Alpha-crystallin B chain Proteins 0.000 description 1
101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 1
101000924474 Homo sapiens Annexin A2 Proteins 0.000 description 1
101000697381 Homo sapiens BET1 homolog Proteins 0.000 description 1
101000914211 Homo sapiens CASP8 and FADD-like apoptosis regulator Proteins 0.000 description 1
101000898052 Homo sapiens Calnexin Proteins 0.000 description 1
101000994700 Homo sapiens Casein kinase I isoform alpha Proteins 0.000 description 1
101000916264 Homo sapiens Catenin delta-1 Proteins 0.000 description 1
101000740981 Homo sapiens Caveolin-2 Proteins 0.000 description 1
101000797581 Homo sapiens Chromobox protein homolog 5 Proteins 0.000 description 1
101000891786 Homo sapiens Cleavage stimulation factor subunit 1 Proteins 0.000 description 1
101000741329 Homo sapiens Cullin-associated NEDD8-dissociated protein 1 Proteins 0.000 description 1
101000922020 Homo sapiens Cysteine and glycine-rich protein 1 Proteins 0.000 description 1
101001018431 Homo sapiens DNA replication licensing factor MCM7 Proteins 0.000 description 1
101000806846 Homo sapiens DNA-(apurinic or apyrimidinic site) endonuclease Proteins 0.000 description 1
101000929217 Homo sapiens Dematin Proteins 0.000 description 1
101000817604 Homo sapiens Dynamin-1 Proteins 0.000 description 1
101000817607 Homo sapiens Dynamin-2 Proteins 0.000 description 1
101000737269 Homo sapiens E3 ubiquitin-protein ligase CBL-C Proteins 0.000 description 1
101000959746 Homo sapiens Eukaryotic translation initiation factor 6 Proteins 0.000 description 1
101000836111 Homo sapiens FACT complex subunit SPT16 Proteins 0.000 description 1
101000997967 Homo sapiens GDNF family receptor alpha-2 Proteins 0.000 description 1
101001032427 Homo sapiens General transcription factor II-I Proteins 0.000 description 1
101001040875 Homo sapiens Glucosidase 2 subunit beta Proteins 0.000 description 1
101000857837 Homo sapiens Guanine nucleotide-binding protein G(o) subunit alpha Proteins 0.000 description 1
101001002695 Homo sapiens Integrin-linked protein kinase Proteins 0.000 description 1
101000852483 Homo sapiens Interleukin-1 receptor-associated kinase 1 Proteins 0.000 description 1
101000998020 Homo sapiens Keratin, type I cytoskeletal 18 Proteins 0.000 description 1
101000891579 Homo sapiens Microtubule-associated protein tau Proteins 0.000 description 1
101001022780 Homo sapiens Myosin light chain kinase, smooth muscle Proteins 0.000 description 1
101001112224 Homo sapiens Neutrophil cytosol factor 2 Proteins 0.000 description 1
101000637249 Homo sapiens Nexilin Proteins 0.000 description 1
101000637342 Homo sapiens Nucleolysin TIAR Proteins 0.000 description 1
101001120056 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit alpha Proteins 0.000 description 1
101000620009 Homo sapiens Polyunsaturated fatty acid 5-lipoxygenase Proteins 0.000 description 1
101001125574 Homo sapiens Prostasin Proteins 0.000 description 1
101000705766 Homo sapiens Proteasome activator complex subunit 3 Proteins 0.000 description 1
101001000061 Homo sapiens Protein phosphatase 1 regulatory subunit 12A Proteins 0.000 description 1
101000655540 Homo sapiens Protransforming growth factor alpha Proteins 0.000 description 1
101000708215 Homo sapiens Ras and Rab interactor 1 Proteins 0.000 description 1
101001130465 Homo sapiens Ras-related protein Ral-A Proteins 0.000 description 1
101001106395 Homo sapiens Rho GTPase-activating protein 5 Proteins 0.000 description 1
101001051706 Homo sapiens Ribosomal protein S6 kinase beta-1 Proteins 0.000 description 1
101100534512 Homo sapiens STMN1 gene Proteins 0.000 description 1
101001094146 Homo sapiens SUMO-activating enzyme subunit 2 Proteins 0.000 description 1
101000939246 Homo sapiens SUMO-conjugating enzyme UBC9 Proteins 0.000 description 1
101000831940 Homo sapiens Stathmin Proteins 0.000 description 1
101000648196 Homo sapiens Striatin Proteins 0.000 description 1
101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
101000733249 Homo sapiens Tumor suppressor ARF Proteins 0.000 description 1
101000621456 Homo sapiens Vesicle transport through interaction with t-SNAREs homolog 1B Proteins 0.000 description 1
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
108010058683 Immobilized Proteins Proteins 0.000 description 1
102100035692 Importin subunit alpha-1 Human genes 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
102100020944 Integrin-linked protein kinase Human genes 0.000 description 1
101710199015 Interleukin-1 receptor-associated kinase 1 Proteins 0.000 description 1
108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 1
102000019145 JUN kinase activity proteins Human genes 0.000 description 1
102220475869 Keratin, type I cytoskeletal 10_R12A_mutation Human genes 0.000 description 1
102100033421 Keratin, type I cytoskeletal 18 Human genes 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
241000283953 Lagomorpha Species 0.000 description 1
101710125058 Leucine aminopeptidase 2, chloroplastic Proteins 0.000 description 1
102000009151 Luteinizing Hormone Human genes 0.000 description 1
108010073521 Luteinizing Hormone Proteins 0.000 description 1
102000043136 MAP kinase family Human genes 0.000 description 1
108091054455 MAP kinase family Proteins 0.000 description 1
PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
108050006284 Matrix metalloproteinase-23 Proteins 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
102000002151 Microfilament Proteins Human genes 0.000 description 1
108010040897 Microfilament Proteins Proteins 0.000 description 1
102000029749 Microtubule Human genes 0.000 description 1
108091022875 Microtubule Proteins 0.000 description 1
102100040243 Microtubule-associated protein tau Human genes 0.000 description 1
102000003794 Mini-chromosome maintenance proteins Human genes 0.000 description 1
108090000159 Mini-chromosome maintenance proteins Proteins 0.000 description 1
241000711408 Murine respirovirus Species 0.000 description 1
101100066898 Mus musculus Flna gene Proteins 0.000 description 1
101000753272 Mus musculus Transcription intermediary factor 1-beta Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
102000003505 Myosin Human genes 0.000 description 1
108060008487 Myosin Proteins 0.000 description 1
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
241001045988 Neogene Species 0.000 description 1
102000017922 Neurotensin receptor Human genes 0.000 description 1
108060003370 Neurotensin receptor Proteins 0.000 description 1
102100023618 Neutrophil cytosol factor 2 Human genes 0.000 description 1
101710168877 Nexilin Proteins 0.000 description 1
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
102000008297 Nuclear Matrix-Associated Proteins Human genes 0.000 description 1
108010035916 Nuclear Matrix-Associated Proteins Proteins 0.000 description 1
102000007999 Nuclear Proteins Human genes 0.000 description 1
108010089610 Nuclear Proteins Proteins 0.000 description 1
108020003217 Nuclear RNA Proteins 0.000 description 1
102000043141 Nuclear RNA Human genes 0.000 description 1
102100024057 Nuclear pore glycoprotein p62 Human genes 0.000 description 1
108090001144 Nuclear receptor coactivator 2 Proteins 0.000 description 1
102100037226 Nuclear receptor coactivator 2 Human genes 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
102100032138 Nucleolysin TIAR Human genes 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
102000003940 Occludin Human genes 0.000 description 1
108090000304 Occludin Proteins 0.000 description 1
206010033128 Ovarian cancer Diseases 0.000 description 1
206010061535 Ovarian neoplasm Diseases 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
239000008118 PEG 6000 Substances 0.000 description 1
241001494479 Pecora Species 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 1
102100037026 Peptidyl-prolyl cis-trans isomerase FKBP5 Human genes 0.000 description 1
102000007982 Phosphoproteins Human genes 0.000 description 1
108010089430 Phosphoproteins Proteins 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
102100022364 Polyunsaturated fatty acid 5-lipoxygenase Human genes 0.000 description 1
241000288906 Primates Species 0.000 description 1
102100031298 Proteasome activator complex subunit 3 Human genes 0.000 description 1
102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
102100036547 Protein phosphatase 1 regulatory subunit 12A Human genes 0.000 description 1
108010026552 Proteome Proteins 0.000 description 1
102000055251 Proto-Oncogene Proteins c-cbl Human genes 0.000 description 1
101150056500 Ptpn6 gene Proteins 0.000 description 1
238000012341 Quantitative reverse-transcriptase PCR Methods 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
102100031485 Ras and Rab interactor 1 Human genes 0.000 description 1
102100027555 Ras-specific guanine nucleotide-releasing factor 2 Human genes 0.000 description 1
108050004795 Ras-specific guanine nucleotide-releasing factor 2 Proteins 0.000 description 1
241000700159 Rattus Species 0.000 description 1
102100025234 Receptor of activated protein C kinase 1 Human genes 0.000 description 1
108010044157 Receptors for Activated C Kinase Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102100021428 Rho GTPase-activating protein 5 Human genes 0.000 description 1
101710108924 Ribosomal protein S6 kinase beta-1 Proteins 0.000 description 1
241000282849 Ruminantia Species 0.000 description 1
108091006629 SLC13A2 Proteins 0.000 description 1
108091006649 SLC9A3 Proteins 0.000 description 1
108010011005 STAT6 Transcription Factor Proteins 0.000 description 1
102100035250 SUMO-activating enzyme subunit 2 Human genes 0.000 description 1
102100029807 SUMO-conjugating enzyme UBC9 Human genes 0.000 description 1
101710169052 SWI/SNF complex subunit SMARCC2 Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
101100325792 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) BAT1 gene Proteins 0.000 description 1
101100189627 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PTC5 gene Proteins 0.000 description 1
101100325791 Schizosaccharomyces pombe (strain 972 / ATCC 24843) eca39 gene Proteins 0.000 description 1
101100082911 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ppp1 gene Proteins 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
102100023980 Signal transducer and activator of transcription 6 Human genes 0.000 description 1
108020004688 Small Nuclear RNA Proteins 0.000 description 1
102000039471 Small Nuclear RNA Human genes 0.000 description 1
102100030375 Sodium/hydrogen exchanger 3 Human genes 0.000 description 1
102100028898 Striatin Human genes 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
102100028808 Syntaxin-8 Human genes 0.000 description 1
108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 1
GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
108010009583 Transforming Growth Factors Proteins 0.000 description 1
102000009618 Transforming Growth Factors Human genes 0.000 description 1
108010040625 Transforming Protein 1 Src Homology 2 Domain-Containing Proteins 0.000 description 1
238000010162 Tukey test Methods 0.000 description 1
102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
102100039094 Tyrosinase Human genes 0.000 description 1
108060008724 Tyrosinase Proteins 0.000 description 1
102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 description 1
102100023018 Vesicle transport through interaction with t-SNAREs homolog 1B Human genes 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
102000013814 Wnt Human genes 0.000 description 1
108050003627 Wnt Proteins 0.000 description 1
210000001766 X chromosome Anatomy 0.000 description 1
108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 1
241000021375 Xenogenes Species 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
238000002679 ablation Methods 0.000 description 1
230000035508 accumulation Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000004913 activation Effects 0.000 description 1
238000011374 additional therapy Methods 0.000 description 1
208000009956 adenocarcinoma Diseases 0.000 description 1
108700010877 adenoviridae proteins Proteins 0.000 description 1
239000002390 adhesive tape Substances 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
229960003896 aminopterin Drugs 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000002280 anti-androgenic effect Effects 0.000 description 1
230000006909 anti-apoptosis Effects 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
239000000051 antiandrogen Substances 0.000 description 1
230000001640 apoptogenic effect Effects 0.000 description 1
230000005775 apoptotic pathway Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000003491 array Methods 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
101150016587 bcat-1 gene Proteins 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
238000007413 biotinylation Methods 0.000 description 1
230000006287 biotinylation Effects 0.000 description 1
239000010836 blood and blood product Substances 0.000 description 1
229940125691 blood product Drugs 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
238000009835 boiling Methods 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
230000017008 border follicle cell migration Effects 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
230000005773 cancer-related death Effects 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
238000000423 cell based assay Methods 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000006369 cell cycle progression Effects 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000004709 cell invasion Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
230000005754 cellular signaling Effects 0.000 description 1
210000003793 centrosome Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
230000010319 checkpoint response Effects 0.000 description 1
230000009920 chelation Effects 0.000 description 1
150000005829 chemical entities Chemical class 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
231100000005 chromosome aberration Toxicity 0.000 description 1
230000006395 clathrin-mediated endocytosis Effects 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
238000002591 computed tomography Methods 0.000 description 1
239000007859 condensation product Substances 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000013068 control sample Substances 0.000 description 1
238000009223 counseling Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
238000012303 cytoplasmic staining Methods 0.000 description 1
210000004292 cytoskeleton Anatomy 0.000 description 1
230000032459 dedifferentiation Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000003412 degenerative effect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000000326 densiometry Methods 0.000 description 1
230000002074 deregulated effect Effects 0.000 description 1
238000003795 desorption Methods 0.000 description 1
239000003599 detergent Substances 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
238000001085 differential centrifugation Methods 0.000 description 1
125000005414 dithiopyridyl group Chemical group 0.000 description 1
238000007878 drug screening assay Methods 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
239000005447 environmental material Substances 0.000 description 1
230000007515 enzymatic degradation Effects 0.000 description 1
235000020774 essential nutrients Nutrition 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
108700002148 exportin 1 Proteins 0.000 description 1
235000013861 fat-free Nutrition 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000001917 fluorescence detection Methods 0.000 description 1
229960002949 fluorouracil Drugs 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000012817 gel-diffusion technique Methods 0.000 description 1
238000011223 gene expression profiling Methods 0.000 description 1
230000030279 gene silencing Effects 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
229960003180 glutathione Drugs 0.000 description 1
101150106093 gpt gene Proteins 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000007773 growth pattern Effects 0.000 description 1
230000035931 haemagglutination Effects 0.000 description 1
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
238000013537 high throughput screening Methods 0.000 description 1
230000001744 histochemical effect Effects 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000000951 immunodiffusion Effects 0.000 description 1
238000000760 immunoelectrophoresis Methods 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
238000012744 immunostaining Methods 0.000 description 1
238000003017 in situ immunoassay Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000006882 induction of apoptosis Effects 0.000 description 1
238000003331 infrared imaging Methods 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000010354 integration Effects 0.000 description 1
238000012482 interaction analysis Methods 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
230000009545 invasion Effects 0.000 description 1
206010073095 invasive ductal breast carcinoma Diseases 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
108010011989 karyopherin alpha 2 Proteins 0.000 description 1
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
210000002415 kinetochore Anatomy 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
238000001325 log-rank test Methods 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
229940040129 luteinizing hormone Drugs 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
206010025482 malaise Diseases 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
238000013507 mapping Methods 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
210000005060 membrane bound organelle Anatomy 0.000 description 1
238000010197 meta-analysis Methods 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000013528 metallic particle Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
208000037819 metastatic cancer Diseases 0.000 description 1
208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
IZAGSTRIDUNNOY-UHFFFAOYSA-N methyl 2-[(2,4-dioxo-1h-pyrimidin-5-yl)oxy]acetate Chemical compound COC(=O)COC1=CNC(=O)NC1=O IZAGSTRIDUNNOY-UHFFFAOYSA-N 0.000 description 1
150000004702 methyl esters Chemical class 0.000 description 1
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
210000004688 microtubule Anatomy 0.000 description 1
210000004939 midgestation embryo Anatomy 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000003147 molecular marker Substances 0.000 description 1
239000003068 molecular probe Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
230000004899 motility Effects 0.000 description 1
210000003097 mucus Anatomy 0.000 description 1
238000000491 multivariate analysis Methods 0.000 description 1
238000010202 multivariate logistic regression analysis Methods 0.000 description 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
229960000951 mycophenolic acid Drugs 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
XJVXMWNLQRTRGH-UHFFFAOYSA-N n-(3-methylbut-3-enyl)-2-methylsulfanyl-7h-purin-6-amine Chemical compound CSC1=NC(NCCC(C)=C)=C2NC=NC2=N1 XJVXMWNLQRTRGH-UHFFFAOYSA-N 0.000 description 1
101150091879 neo gene Proteins 0.000 description 1
230000010309 neoplastic transformation Effects 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
108010007451 neutrophil cytosol factor 67K Proteins 0.000 description 1
238000010606 normalization Methods 0.000 description 1
230000004942 nuclear accumulation Effects 0.000 description 1
210000000633 nuclear envelope Anatomy 0.000 description 1
210000000299 nuclear matrix Anatomy 0.000 description 1
238000012758 nuclear staining Methods 0.000 description 1
230000001293 nucleolytic effect Effects 0.000 description 1
229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
231100000590 oncogenic Toxicity 0.000 description 1
230000002246 oncogenic effect Effects 0.000 description 1
230000006548 oncogenic transformation Effects 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
230000005298 paramagnetic effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
230000035699 permeability Effects 0.000 description 1
238000001558 permutation test Methods 0.000 description 1
239000012071 phase Substances 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
230000001817 pituitary effect Effects 0.000 description 1
239000000902 placebo Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
238000010837 poor prognosis Methods 0.000 description 1
230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
230000001124 posttranscriptional effect Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
208000037821 progressive disease Diseases 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
108010031970 prostasin Proteins 0.000 description 1
210000000064 prostate epithelial cell Anatomy 0.000 description 1
238000011471 prostatectomy Methods 0.000 description 1
201000007094 prostatitis Diseases 0.000 description 1
238000013197 protein A assay Methods 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
239000012474 protein marker Substances 0.000 description 1
230000018883 protein targeting Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
102000005912 ran GTP Binding Protein Human genes 0.000 description 1
108010005597 ran GTP Binding Protein Proteins 0.000 description 1
102000001378 ras Guanine Nucleotide Exchange Factors Human genes 0.000 description 1
108010080092 ras Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
108091008598 receptor tyrosine kinases Proteins 0.000 description 1
102000027426 receptor tyrosine kinases Human genes 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000000611 regression analysis Methods 0.000 description 1
230000022983 regulation of cell cycle Effects 0.000 description 1
239000003488 releasing hormone Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000012502 risk assessment Methods 0.000 description 1
235000002020 sage Nutrition 0.000 description 1
238000005185 salting out Methods 0.000 description 1
239000012723 sample buffer Substances 0.000 description 1
SIXSYDAISGFNSX-NJFSPNSNSA-N scandium-47 Chemical compound [47Sc] SIXSYDAISGFNSX-NJFSPNSNSA-N 0.000 description 1
238000003345 scintillation counting Methods 0.000 description 1
238000013077 scoring method Methods 0.000 description 1
239000012679 serum free medium Substances 0.000 description 1
108091006024 signal transducing proteins Proteins 0.000 description 1
102000034285 signal transducing proteins Human genes 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000002356 single layer Substances 0.000 description 1
238000002603 single-photon emission computed tomography Methods 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000002689 soil Substances 0.000 description 1
239000006104 solid solution Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
238000003153 stable transfection Methods 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
102000005969 steroid hormone receptors Human genes 0.000 description 1
108020003113 steroid hormone receptors Proteins 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000013517 stratification Methods 0.000 description 1
230000010741 sumoylation Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
230000008685 targeting Effects 0.000 description 1
229940056501 technetium 99m Drugs 0.000 description 1
229960003604 testosterone Drugs 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
238000003161 three-hybrid assay Methods 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
238000003325 tomography Methods 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
238000003146 transient transfection Methods 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
239000003656 tris buffered saline Substances 0.000 description 1
IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 1
125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
230000004614 tumor growth Effects 0.000 description 1
230000005760 tumorsuppression Effects 0.000 description 1
238000003160 two-hybrid assay Methods 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
238000010798 ubiquitination Methods 0.000 description 1
230000034512 ubiquitination Effects 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
210000000605 viral structure Anatomy 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000008096 xylene Substances 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
230000004572 zinc-binding Effects 0.000 description 1
210000004340 zona pellucida Anatomy 0.000 description 1